WYPH Stock Chart & Stats
<$0.01
<$0.01(7.69%)
At close: 4:00 PM EDT
<$0.01
<$0.01(7.69%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.08
Previous CloseN/A
Volume19.81K
Average Volume (3M)1.29M
Market Cap
$52.39K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-98.75
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding37,421,000
10 Day Avg. Volume1,292,944
30 Day Avg. Volume1,292,944
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
WYPH FAQ
What was WayPoint Biomedical Holdings Inc’s price range in the past 12 months?
WayPoint Biomedical Holdings Inc lowest stock price was <$0.01 and its highest was $0.08 in the past 12 months.
What is WayPoint Biomedical Holdings Inc’s market cap?
WayPoint Biomedical Holdings Inc’s market cap is $52.39K.
When is WayPoint Biomedical Holdings Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were WayPoint Biomedical Holdings Inc’s earnings last quarter?
Currently, no data Available
Is WayPoint Biomedical Holdings Inc overvalued?
According to Wall Street analysts WayPoint Biomedical Holdings Inc’s price is currently Overvalued.
Does WayPoint Biomedical Holdings Inc pay dividends?
WayPoint Biomedical Holdings Inc does not currently pay dividends.
What is WayPoint Biomedical Holdings Inc’s EPS estimate?
WayPoint Biomedical Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does WayPoint Biomedical Holdings Inc have?
WayPoint Biomedical Holdings Inc has 37,421,000 shares outstanding.
What happened to WayPoint Biomedical Holdings Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of WayPoint Biomedical Holdings Inc?
Currently, no hedge funds are holding shares in WYPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
WayPoint Biomedical Holdings Inc
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.